Benzingaflipped into Health & BiotechGlaucoma Skye Bioscience Is Utilizing A Novel THC-Derivative To Treat Glaucoma benzinga.com - Sarah Traisman Skye Bioscience, formally Emerald Bioscience, was one of the sponsors for the Benzinga Global Small Cap Conference that took place on December 8-9, …
ForbesCOVID-19 Vaccine Johnson & Johnson’s Covid-19 Vaccine Updates: Efficacy Figures, Production Delays Forbes - Trefis TeamJohnson & Johnson (NYSE: JNJ) is developing one of the most closely watched Covid-19 vaccines, considering that it is a single-dose shot that should be relatively easy to distribute. Here’s a quick rundown...
Seeking Alphaflipped into Breaking NewsCapital Markets Gritstone and Genevant Sciences ink license agreement for COVID-19 vaccine (NASDAQ:GRTS) verified_publisherSeeking Alpha - Khyathi Dalal, SA News Editor • Gritstone Oncology (NASDAQ:GRTS) and Genevant Sciences, nucleic acid delivery company with world-class platforms and the industry's most robust and …
Benzingaflipped into Health & BiotechNasdaqThe Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For... benzinga.com - Shanthi Rexaline , Benzinga Staff Writer Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 19) 4D …
The Motley FoolFinance Is Inovio Pharmaceuticals a Buy? verified_publisherThe Motley Fool - David Jagielski The biotech company's COVID-19 vaccine candidate may not be near the finish line, but that doesn't mean investors should count it out just yet. To say …
Benzingaflipped into Health & BiotechJoe Biden Biden's Day One Executive Orders Agenda To Include Health, Equality, Climate Change, Halt Trump Legacy Orders benzinga.com - Mohit Manghnani Incoming President Joe Biden aides said that the President would sign more executive orders on Day One than any of his predecessors, followed by …
